CLOV Clover Health Investments, Corp. - Class A Common stock
$3,54
Prix · Mai 20, 2026
Données fondamentales au Mai 8, 2026
Fourchette 52 semaines
$2–$4
84% of range
Note des analystes
BUY
10 analysts
Objectif de cours
$3
P/E (TTM)
-5.1
ROE
-26.2%
Marge nette
-4.5%
CLOV Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.54
Capitalisation Boursière
—
P/E (TTM)
-5.1
BPA (TTM)
$-0.44
Revenus (TTM)
$1.92B
Rendement div.
—
ROE
-26.2%
Dette/Capitaux propres
—
Fourchette 52 semaines
$2 – $4
CLOV Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$1.92B
2022-12-31
→
2025-12-31
BPA
$-0.44
2022-12-31
→
2023-12-31
Flux de trésorerie libre
$-69M
2022-12-31
→
2025-12-31
Marges
-4.5%
2022-12-31
→
2023-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
CLOV
Médiane des pairs
P/E (TTM)
-5.1
23.9
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
CLOV
Médiane des pairs
Operating Margin (Marge d'exploitation)
-4.4%
—
Net Profit Margin (Marge nette)
-4.5%
0.98%
ROA
-15.2%
2.7%
ROE
-26.2%
7.8%
ROIC
-27.7%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
CLOV
Médiane des pairs
Current Ratio (Ratio de liquidité)
1.5
1.6
Quick Ratio (Ratio de liquidité réduite)
0.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
CLOV
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
40.3%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
20.6%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
23.4%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
CLOV
Médiane des pairs
CLOV Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
10 analystes
- Achat fort 2 20,0%
- Achat 4 40,0%
- Conserver 4 40,0%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
3 analystes · 2026-05-20
Médiane
$2.75
Moyenne
$2.82
Au-dessus de tous les objectifs →
$3.54
Bas
$2.50
Haut
$3.20
Objectif médian
$2.75
-22,2%
Objectif moyen
$2.82
-20,3%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.02%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $0.07 | $0.03 | 0.04% |
| 31 décembre 2025 | $-0.10 | $-0.11 | 0.01% |
| 30 septembre 2025 | $-0.05 | $-0.03 | -0.02% |
| 30 juin 2025 | $-0.02 | $-0.03 | 0.01% |
| 31 mars 2025 | $0.00 | $-0.06 | 0.06% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | $462M | |
| Gross Profit | · | · | $257M | $70M | $-79M | · | · | |
| SG&A Expense | $214M | $176M | $183M | $204M | $185M | $121M | $96M | |
| Operating Expenses | $2.01B | $1.42B | $1.47B | $1.38B | $2.11B | $766M | $645M | |
| Operating Income | $-86M | $-46M | $-205M | $-287M | $-637M | $-93M | $-183M | |
| Interest Expense | · | · | $7.0K | $1M | $3M | $36M | $23M | |
| Interest Income | · | · | · | · | · | $117.3K | · | |
| Pretax Income | $-86M | $-43M | $-213M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | $-364M | |
| EPS (Basic) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| EPS (Diluted) | · | · | $-0.44 | $-0.71 | $-1.42 | $-1.54 | $-4.14 | |
| Shares (Basic) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| Shares (Diluted) | 511,967,146 | 490,018,730 | 482,176,127 | 476,244,262 | 412,922,424 | 88,691,582 | 87,829,419 | |
| EBITDA | $-87M | $-48M | $-213M | $-372M | $-637M | $-7M | · |
Bilan 26
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $195M | $123M | $104M | $300M | $92M | $68M | |
| Short-term Investments | · | · | · | · | · | $0 | · | |
| Prepaid Expense | $18M | $13M | $14M | $18M | $15M | $8M | $0 | |
| Other Current Assets | $11M | $16M | $19M | $4M | $3M | $299.0K | · | |
| Current Assets | $308M | $343M | $428M | $625M | $753M | $190M | $0 | |
| PP&E (Net) | $6M | $5M | $5M | $6M | $2M | $2M | · | |
| PP&E (Gross) | $14M | $11M | $10M | $8M | $5M | $4M | · | |
| Accum. Depreciation | $8M | $6M | $5M | $2M | $2M | $2M | · | |
| Goodwill | · | · | $0 | $12M | $1M | $1M | · | |
| Other Non-current Assets | $24M | $13M | $14M | $16M | $10M | $9M | · | |
| Total Assets | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Accounts Payable | $36M | $35M | $37M | $32M | $28M | $31M | · | |
| Accrued Liabilities | · | · | · | · | · | $5M | $0 | |
| Current Liabilities | $209M | $214M | $261M | $432M | $372M | $164M | $118.0K | |
| Capital Leases | · | · | $3M | $4M | $5M | $6M | · | |
| Other Non-current Liabilities | $23M | $26M | $23M | $16M | $14M | $13M | · | |
| Total Liabilities | $232M | $240M | $284M | $452M | $411M | $433M | $118.0K | |
| Long-term Debt | · | · | · | · | $20M | $127M | · | |
| Total Debt | · | · | · | $0 | $20M | · | · | |
| Paid-in Capital | $2.68B | $2.58B | $2.46B | $2.32B | $2.15B | $412M | $0 | |
| Retained Earnings | $-2.29B | $-2.20B | $-2.16B | $-1.95B | $-1.62B | $-1.03B | $-17.6K | |
| Treasury Stock | $86M | $31M | $13M | $7M | $147.0K | $0 | · | |
| AOCI | $528.0K | $-2M | $-2M | $-9M | $-2M | $10.0K | · | |
| Stockholders' Equity | $309M | $341M | $286M | $357M | $540M | $-613M | $-17.6K | |
| Liabilities + Equity | $541M | $581M | $571M | $809M | $951M | $267M | $100.3K | |
| Shares Outstanding | · | · | · | · | 470,852,394 | 89,206,266 | · |
Flux de trésorerie 16
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $-2M | $-3M | $-4M | $-2M | $200.0K | $-195.0K | $-3M | |
| Stock-based Comp | $104M | $114M | $141M | $164M | $164M | $7M | $3M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $2.0K | $2.0K | |
| Amort. of Intangibles | · | · | · | $100.0K | $700.0K | · | · | |
| Restructuring | · | $288.0K | $10M | $0 | · | · | · | |
| Other Non-cash | $-83M | $-34M | $-39M | $-28M | $142M | · | · | |
| Operating Cash Flow | $-67M | $35M | $-145M | $-204M | $-282M | $-118M | $-160M | |
| CapEx | $2M | $2M | $584.0K | $4M | $723.0K | $693.0K | $23.0K | |
| Investing Cash Flow | $4M | $565.0K | $140M | $95M | $-435M | $137M | $-182M | |
| Stock Issued | $1M | $193.0K | $1M | $0 | $284M | $0 | $0 | |
| Stock Repurchased | $18M | $2M | $0 | $0 | $147.0K | $0 | $0 | |
| Net Stock Activity | $-17M | $-2M | $-6M | $-6M | $284M | $25.0K | · | |
| Financing Cash Flow | $-53M | $-17M | $-5M | $-5M | $925M | $6M | $334M | |
| Net Change in Cash | $-116M | $18M | $-10M | $-114M | $208M | $25M | $-8M | |
| Taxes Paid | $0 | · | · | · | · | · | · | |
| Free Cash Flow | $-69M | $33M | $-116M | $-208M | $-283M | · | · |
Rentabilité 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 12.7% | 0.65% | -5.4% | · | · | |
| Operating Margin | -4.4% | -3.3% | -10.2% | -10.7% | -43.3% | · | · | |
| Net Margin | -4.5% | -3.1% | -10.5% | -9.8% | -39.9% | · | · | |
| Pretax Margin | -4.5% | · | · | · | · | · | · | |
| EBITDA Margin | -4.5% | -3.5% | -10.4% | -10.7% | -43.3% | · | · | |
| ROA | -15.2% | -7.5% | -34.0% | -28.6% | -61.8% | -1.6% | · | |
| ROE | -26.2% | -12.6% | -70.2% | -91.6% | 1511.3% | -134.9% | · | |
| ROIC | -27.7% | · | · | · | · | · | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.6 | 1.6 | 1.4 | 2.0 | 0.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.5 | 0.2 | 0.8 | 0.8 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | -29791.7 | -278.3 | -197.3 | · | · |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 3.4 | 2.4 | 3.2 | 2.9 | 1.5 | · | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.3% | 8.8% | 15.0% | -25.5% | 118.8% | · | · | |
| Revenue CAGR 3Y | 20.6% | -2.3% | 23.3% | · | · | · | · | |
| Revenue CAGR 5Y | 23.4% | · | · | · | · | · | · |
Valorisation (TTM) 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $673M | · | |
| Net Income TTM | $-86M | $-43M | $-213M | $-340M | $-588M | $-136M | · | |
| P/E | -5.1 | -6.8 | -2.2 | -1.3 | -2.6 | -10.9 | · | |
| Earnings Yield | -19.6% | -14.6% | -46.2% | -76.3% | -38.2% | -9.2% | · |
Compte de résultat 12
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $749M | $488M | $497M | $478M | $462M | $337M | $331M | $356M | $347M | $306M | $320M | $322M | $857M | $847M | $874M | $432M | |
| Gross Profit | · | · | · | · | · | · | $81M | $108M | $82M | $70M | $76M | $47M | $17M | $-12M | $13M | · | |
| SG&A Expense | $75M | $66M | $49M | $48M | $51M | $52M | $35M | $44M | $45M | $41M | $42M | $58M | $48M | $47M | $58M | $55M | |
| Operating Expenses | $722M | $537M | $521M | $488M | $464M | $358M | $340M | $349M | $370M | $340M | $349M | $402M | $931M | $949M | $962M | $619M | |
| Operating Income | $27M | $-49M | $-24M | $-11M | $-1M | $-21M | $-9M | $7M | $-23M | $-34M | $-29M | $-80M | $-74M | $-103M | $-87M | $-187M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $7.0K | $0 | $404.0K | $390.0K | $403.0K | $403.0K | |
| Net Income | $27M | $-49M | $-24M | $-11M | $-1M | $-22M | $-9M | $7M | $-19M | $-41M | $-29M | $-73M | $-75M | $-104M | $-75M | $-187M | |
| EPS (Basic) | $0.05 | · | · | · | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | $-0.43 | |
| EPS (Diluted) | $0.05 | · | · | · | $0.00 | · | · | · | · | $-0.09 | $-0.06 | $-0.15 | $-0.16 | $-0.22 | $-0.16 | $-0.43 | |
| Shares (Basic) | 522,184,385 | -1,006,875,916 | 512,743,521 | 509,043,210 | 497,056,331 | -974,019,104 | 490,180,103 | 487,483,087 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | -785,977,509 | |
| Shares (Diluted) | 532,501,448 | -1,006,875,916 | 512,743,521 | 509,043,210 | 497,056,331 | -981,715,972 | 490,180,103 | 495,179,955 | 486,374,644 | 480,770,283 | 479,163,752 | 478,805,067 | 477,690,204 | 476,061,809 | 473,028,651 | -785,977,509 | |
| EBITDA | $27M | · | $-24M | $-11M | $-2M | · | $-9M | $7M | $-23M | $-41M | $-29M | $-74M | $-74M | $-103M | $-87M | · |
Bilan 24
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $78M | · | · | · | $195M | $288M | $255M | $208M | $299M | $310M | $191M | $383M | $324M | $274M | $300M | |
| Prepaid Expense | $18M | $18M | $12M | $15M | $17M | $13M | $13M | $15M | $17M | $15M | $15M | $17M | $18M | $20M | $22M | · | |
| Other Current Assets | $23M | $11M | $12M | $15M | $16M | $16M | $3M | $4M | $5M | $1M | $3M | $3M | $37M | $26M | $17M | · | |
| Current Assets | $448M | $308M | $331M | $363M | $331M | $343M | $433M | $550M | $553M | $916M | $1.13B | $1.27B | $1.46B | $1.86B | $2.49B | · | |
| PP&E (Net) | $7M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $3M | $2M | $2M | · | |
| PP&E (Gross) | · | $14M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | $8M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Other Non-current Assets | $25M | $24M | $27M | $16M | $14M | $13M | $11M | $10M | $10M | $15M | $15M | $15M | $15M | $15M | $15M | · | |
| Total Assets | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | · | |
| Accounts Payable | $39M | $36M | $33M | $34M | $31M | $35M | $26M | $40M | $35M | $35M | $40M | $47M | $38M | $30M | $27M | · | |
| Current Liabilities | $337M | $209M | $193M | $202M | $216M | $214M | $280M | $325M | $356M | $719M | $908M | $1.11B | $1.13B | $1.60B | $2.15B | $372M | |
| Capital Leases | · | · | · | · | · | · | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | · | |
| Other Non-current Liabilities | $22M | $23M | $25M | $29M | $32M | $26M | $29M | $22M | $20M | $16M | $16M | $16M | $13M | $13M | $13M | · | |
| Total Liabilities | $358M | $232M | $219M | $231M | $248M | $240M | $311M | $349M | $379M | $738M | $927M | $1.13B | $1.17B | $1.64B | $2.19B | $411M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | $20M | · | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | $20M | $20M | $20M | · | |
| Paid-in Capital | $2.70B | $2.68B | $2.66B | $2.63B | $2.60B | $2.58B | $2.55B | $2.52B | $2.49B | $2.43B | $2.40B | $2.36B | $2.28B | $2.24B | $2.20B | · | |
| Retained Earnings | $-2.26B | $-2.29B | $-2.24B | $-2.21B | $-2.20B | $-2.20B | $-2.18B | $-2.17B | $-2.18B | $-2.09B | $-2.05B | $-2.02B | $-1.87B | $-1.80B | $-1.69B | $-1.62B | |
| Treasury Stock | $94M | $86M | $77M | $71M | $63M | $31M | $24M | $19M | $16M | $12M | $10M | $9M | $6M | $6M | $6M | · | |
| AOCI | $-672.0K | $528.0K | $471.0K | $177.0K | $-74.0K | $-2M | $852.0K | $-2M | $-3M | $-5M | $-7M | $-7M | $-11M | $-8M | $-7M | · | |
| Stockholders' Equity | $339M | $309M | $341M | $344M | $336M | $341M | $342M | $325M | $292M | $322M | $331M | $323M | $392M | $427M | $490M | $540M | |
| Liabilities + Equity | $698M | $541M | $560M | $575M | $584M | $581M | $653M | $674M | $672M | $1.06B | $1.26B | $1.45B | $1.56B | $2.06B | $2.68B | $951M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | 477,403,782 | · | · |
Flux de trésorerie 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $-441.0K | $-501.0K | $-396.0K | $-509.0K | $-437.0K | $-384.0K | $-522.0K | $-947.0K | $-671.0K | $-954.0K | $-930.0K | $-3M | $-695.0K | $-18.0K | $-17.0K | $58.0K | |
| Stock-based Comp | $12M | $25M | $26M | $26M | $26M | $30M | $28M | $28M | $29M | $33M | $36M | $39M | $43M | $42M | $41M | $31M | |
| Restructuring | · | · | · | · | · | · | $-538.0K | $473.0K | $353.0K | $1M | $5M | $2M | · | · | · | · | |
| Other Non-cash | $69M | · | · | · | $-41M | · | · | · | $17M | · | · | $114M | · | · | $-22M | · | |
| Operating Cash Flow | $108M | $-68M | $12M | $5M | $-16M | $-86M | $50M | $45M | $26M | $-19M | $53M | $79M | $102M | $-39M | $-57M | $-80M | |
| CapEx | $854.0K | $597.0K | $692.0K | $569.0K | $185.0K | $315.0K | $399.0K | $397.0K | $445.0K | $243.0K | $354.0K | $251.0K | $259.0K | $173.0K | $158.0K | $238.0K | |
| Investing Cash Flow | $-5M | $-35M | $-5M | $36M | $9M | $-1M | $-12M | $5M | $9M | $-20M | $66M | $10M | $-43M | $89M | $37M | $-106M | |
| Stock Issued | · | $541.0K | $0 | · | · | $193.0K | $0 | · | · | · | · | · | · | · | · | $278M | |
| Stock Repurchased | $0 | $0 | $1.0K | $0 | $18M | $0 | $0 | $-2M | $0 | $-3M | $-3M | $3M | $276.0K | $105.0K | $6M | $0 | |
| Net Stock Activity | $0 | · | · | · | $-18M | · | · | · | $-3M | · | · | $-3M | · | · | $-6M | · | |
| Financing Cash Flow | $-8M | $-9M | $-5M | $-8M | $-32M | $-6M | $-5M | $-3M | $-3M | $-2M | $-147.0K | $-2M | $132.0K | $458.0K | $-6M | $284M | |
| Net Change in Cash | $95M | $-112M | $1M | $33M | $-39M | $-93M | $33M | $47M | $32M | $-41M | $120M | $87M | $58M | $51M | $-26M | $98M | |
| Free Cash Flow | $107M | · | · | · | $-16M | · | · | · | $25M | · | · | $79M | · | · | $-57M | · |
Rentabilité 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 24.5% | 30.3% | 23.6% | 13.1% | 14.9% | 10.5% | 2.0% | -1.4% | 1.5% | · | |
| Operating Margin | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.6% | 2.0% | -6.5% | -8.6% | -5.6% | -13.8% | -8.6% | -12.1% | -10.0% | · | |
| Net Margin | 3.6% | · | -4.9% | -2.2% | -0.28% | · | -2.8% | 2.1% | -5.5% | -8.6% | -5.6% | -13.8% | -8.8% | -12.3% | -8.6% | · | |
| EBITDA Margin | 3.6% | · | -4.9% | -2.2% | -0.37% | · | -2.6% | 2.0% | -6.7% | -8.6% | -5.6% | -13.9% | -8.6% | -12.1% | -10.0% | · | |
| ROA | 4.3% | · | -4.0% | -1.7% | -0.20% | · | -1.1% | 0.77% | -1.8% | -3.2% | -1.7% | -3.5% | -6.0% | -6.3% | -4.2% | · | |
| ROE | 8.1% | · | -7.1% | -3.2% | -0.41% | · | -2.8% | 2.3% | -6.2% | -11.6% | -7.6% | -17.9% | -18.8% | -28.2% | -14.0% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | · | 1.7 | 1.8 | 1.5 | · | 1.5 | 1.7 | 1.6 | 1.3 | 1.2 | 1.1 | 1.3 | 1.2 | 1.2 | · | |
| Quick Ratio | · | · | · | · | · | · | 1.0 | 0.8 | 0.6 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.1 | · | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | 0.0 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 | 0.0 | 0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -4115.3 | · | -183.0 | -262.9 | -216.6 | · |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | · | 0.8 | 0.8 | 0.7 | · | 0.4 | 0.4 | 0.3 | 0.4 | 0.3 | 0.3 | 0.7 | 0.5 | 0.5 | · |
Valorisation (TTM) 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.19B | · | $1.77B | $1.63B | $1.50B | · | $1.34B | $1.33B | $1.30B | $1.80B | $2.35B | $2.90B | $3.01B | $2.56B | $1.91B | · | |
| Net Income TTM | $-9M | · | $-45M | $-14M | $-22M | · | $-62M | $-82M | $-162M | $-218M | $-281M | $-328M | $-290M | $-532M | $-476M | · | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.02B | · | · | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $717M | · | · | |
| P/E | · | · | -6.7 | -6.1 | -7.8 | · | -6.1 | -2.7 | -1.7 | -2.3 | -1.5 | -1.2 | -2.7 | -1.7 | -3.1 | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | · | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | · | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | 2.4 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | -7.0 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.3 | · | · | |
| Earnings Yield | · | · | -15.0% | -16.5% | -12.8% | · | -16.3% | -37.4% | -57.9% | -42.6% | -65.8% | -81.7% | -36.5% | -57.9% | -32.4% | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Revenu | $1.92B | $1.37B | $1.26B | — | — |
| Marge Brute % | — | — | 12.7% | — | — |
| Marge d'exploitation % | -4.4% | -3.3% | -10.2% | — | — |
| Résultat net | $-86M | $-43M | $-213M | — | — |
| BPA dilué | — | — | $-0.44 | — | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 1.5 | 1.6 | 1.6 | — | — |
| Ratio de liquidité réduite | 0.4 | 0.9 | 0.5 | — | — |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-69M | $33M | $-116M | — | — |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.